Research graph
References from Challenging assumptions about immunosuppression in fibrotic interstitial lung disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
10.1056/nejmoa1113354 · 2012 · External reference
Cyclophosphamide versus placebo in scleroderma lung disease
10.1056/nejmoa055120 · 2006 · External reference
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
10.1016/s2213-2600(22)00359-9 · 2023 · External reference
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
10.1016/s2213-2600(16)30152-7 · 2016 · External reference
Treatment outcomes for rheumatoid arthritis associated interstitial lung disease; a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory
10.1016/j.chest.2022.11.035 · 2023 · External reference
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts
10.1136/thorax-2024-222367 · 2025 · External reference
Role of radiographic fibrosis extent in identifying immunomodulatory treatment response in hypersensitivity pneumonitis
10.1016/j.chest.2025.12.007 · 2026 · External reference
Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis
10.1164/rccm.201809-1646oc · 2019 · External reference
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis
10.1183/13993003.02872-2020 · 2021 · External reference
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
10.1183/13993003.00441-2023 · 2023 · External reference
Azathioprine response in patients with fibrotic connective tissue disease–associated interstitial lung disease
10.1016/j.rmed.2016.11.007 · 2016 · External reference
Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis
10.1016/j.chest.2016.10.029 · 2017 · External reference
10.1093/ajrccm/aamag362 · 2026 · Admitted local publication
